Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACT: Maintenance Bevacizumab +/- Erlotinib in mCRC
NCT00598156Phase 3Completed
- Sponsor
- Skåne University Hospital
- Start
- Jun 2007
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of erlotinib in metastatic colorectal cancer (mCRC), sponsored by Skåne University Hospital. Started Jun 2007; status: completed.
02
Drugs
erlotinib
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00598156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00598156.